CD8A and melanoma: Moreover, the genetic deletion of CISH, in a mouse model of melanoma, significantly increases CD8+ T cells related cytokines production (IFNγ, TNFα, and IL-2) and anti-tumor reactivity, improving the survival of mice for more than 60 days.